Request This Service » 

The Therapeutic Advisory Panel (TAP), which is part of the CCTS Drug Discovery and Development Core (D3), serves as the peer review panel for D3 pilot applications and provides consultation on drug discovery and development projects.

TAP composed of faculty with expertise in the disciplines of drug discovery and design, drug development and delivery, preclinical and clinical pharmacology, regulatory and commercialization. Faculty with content expertise relevant to specific projects, including cancer, substance use disorder, neuroscience, obesity, and cardiovascular science participate as ad hoc members when discipline-specific expertise is required.

We facilitate the discovery of novel pharmacological targets, the conceptualization and design of new compounds, the optimization of lead compounds, and the stewardship of the clinical candidates through pharmaceutical development and all phases of clinical trials and commercialization. 

The TAP members are:

Michael Bardo, PhD
College of Medicine

Terrence A. Barrett, MD
College of Medicine

Thomas Curry, PhD
College of Medicine

Linda Dwoskin, PhD
College of Pharmacy

Sylvie Garneau-Tsodikova, PhD
College of Pharmacy 

Don Gash, PhD
College of Arts and Sciences

Gregory Graf, PhD
College of Pharmacy 

Edward Hall, PhD
College of Medicine

Mark Leggas, PhD
College of Pharmacy 

Michell Lofwall, MD
College of Medicine 

Ian McClure, JD
Office of Technology Commercialization

Rachel Miller, MD
College of Medicine

Jon Thorson, PhD
College of Pharmacy

David Watt, PhD
College of Medicine, College of Arts and Sciences

Chang-Guo Zhan, PhD
College of Pharmacy
 

Related Service: Drug Development & Discovery »

Learn more about the Drug Discovery and Development Core. »